Skip to content
← Full study record

NCT01096342 · MORE INFO

Limitations, agreements, and source contact

Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma · Source last updated 2014-06-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
kumar.shaji@mayo.edu
organization
Mayo Clinic Cancer Center
title
Shaji Kumar, M.D.
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
kumar.shaji@mayo.edu
organization
Mayo Clinic Cancer Center
title
Shaji Kumar, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice